148 related articles for article (PubMed ID: 28461099)
101. Imaging-guided delivery of RNAi for anticancer treatment.
Wang J; Mi P; Lin G; Wáng YX; Liu G; Chen X
Adv Drug Deliv Rev; 2016 Sep; 104():44-60. PubMed ID: 26805788
[TBL] [Abstract][Full Text] [Related]
102. Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.
Riaz MK; Riaz MA; Zhang X; Lin C; Wong KH; Chen X; Zhang G; Lu A; Yang Z
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315231
[TBL] [Abstract][Full Text] [Related]
103. Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy.
Kalra J; Baker J; Sun X; Kyle A; Minchinton A; Bally MB
J Transl Med; 2024 Jul; 22(1):621. PubMed ID: 38961395
[TBL] [Abstract][Full Text] [Related]
104. Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells.
Shopsowitz KE; Wu C; Liu G; Dreaden EC; Hammond PT
Nucleic Acids Res; 2016 Jan; 44(2):545-57. PubMed ID: 26704983
[TBL] [Abstract][Full Text] [Related]
105. I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors.
Ando-Matsuoka R; Ando H; Abu Lila AS; Maeda N; Shimizu T; Ishima Y; Ishida T
J Control Release; 2022 Jan; 341():524-532. PubMed ID: 34896447
[TBL] [Abstract][Full Text] [Related]
106.
Saavedra-Alonso S; Zapata-Benavides P; Chavez-Escamilla AK; Manilla-Muñoz E; Zamora-Avila DE; Franco-Molina MA; Rodriguez-Padilla C
Exp Ther Med; 2016 Dec; 12(6):3778-3784. PubMed ID: 28105110
[TBL] [Abstract][Full Text] [Related]
107. Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.
Cheraga N; Ouahab A; Shen Y; Huang NP
Biomed Res Int; 2021; 2021():5949804. PubMed ID: 33987441
[TBL] [Abstract][Full Text] [Related]
108. Systemic tumor-specific gene delivery.
Kullberg M; McCarthy R; Anchordoquy TJ
J Control Release; 2013 Dec; 172(3):730-6. PubMed ID: 24035974
[TBL] [Abstract][Full Text] [Related]
109. Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.
McCaskill J; Singhania R; Burgess M; Allavena R; Wu S; Blumenthal A; McMillan NA
Mol Ther Nucleic Acids; 2013 Jun; 2(6):e96. PubMed ID: 23736774
[TBL] [Abstract][Full Text] [Related]
110. Multistep, effective drug distribution within solid tumors.
Shemi A; Khvalevsky EZ; Gabai RM; Domb A; Barenholz Y
Oncotarget; 2015 Nov; 6(37):39564-77. PubMed ID: 26416413
[TBL] [Abstract][Full Text] [Related]
111. Guanidine modified polyethyleneimine-g-polyethylene glycol nanocarriers for long interfering RNA (liRNA) based advanced anticancer therapy.
Sajeesh S; Choe JY; Lee TY; Lee DK
J Mater Chem B; 2015 Jan; 3(2):207-216. PubMed ID: 32261941
[TBL] [Abstract][Full Text] [Related]
112. Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies.
Barzegari Firouzabadi F; Oryan SH; Sheikhha MH; Kalantar SM; Javed A
Cell J; 2019 Jul; 21(2):135-142. PubMed ID: 30825286
[TBL] [Abstract][Full Text] [Related]
113. Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice.
Yoshikawa N; Fumoto S; Yoshikawa K; Hu D; Okami K; Kato R; Nakashima M; Miyamoto H; Nishida K
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32290201
[TBL] [Abstract][Full Text] [Related]
114. Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.
Betker JL; Anchordoquy TJ
J Pharm Sci; 2017 Mar; 106(3):872-881. PubMed ID: 27887890
[TBL] [Abstract][Full Text] [Related]
115. A mammalian functional-genetic approach to characterizing cancer therapeutics.
Jiang H; Pritchard JR; Williams RT; Lauffenburger DA; Hemann MT
Nat Chem Biol; 2011 Feb; 7(2):92-100. PubMed ID: 21186347
[TBL] [Abstract][Full Text] [Related]
116. RNA Oncological Therapeutics: Intracellular Hairpin RNA Assembly Enables MicroRNA-Triggered Anticancer Functionality.
Morihiro K; Morita S; Harada N; Baba M; Yum J; Naito M; Miyata K; Nagae G; Okamoto A
J Am Chem Soc; 2024 Jan; 146(2):1346-1355. PubMed ID: 38170469
[TBL] [Abstract][Full Text] [Related]
117. Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers.
Jeong E; Lee Y; Kim Y; Lee J; Yoon S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114107
[TBL] [Abstract][Full Text] [Related]
118. Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA.
Jin X; Sun T; Zhao C; Zheng Y; Zhang Y; Cai W; He Q; Taira K; Zhang L; Zhou D
Nucleic Acids Res; 2021 Jan; 49(1):600. PubMed ID: 33313865
[No Abstract] [Full Text] [Related]
119. RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators.
Guan C; Chernyak N; Dominguez D; Cole L; Zhang B; Mirkin CA
Small; 2019 Oct; 15(43):e1903338. PubMed ID: 31637852
[No Abstract] [Full Text] [Related]
120. The Potential of Optimized Liposomes in Enhancement of Cytotoxicity and Apoptosis of Encapsulated Egyptian Propolis on Hep-2 Cell Line.
El-Aziz EAEA; Elgayar SF; Mady FM; Abourehab MAS; Hasan OA; Reda LM; Alaaeldin E
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
